Abciximab nonclinical toxicology

Revision as of 19:55, 29 January 2014 by Gerald Chi (talk | contribs) (Created page with "__NOTOC__ {{Abciximab}} {{CMG}}; {{AE}} {{SS}}, {{PB}} <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = REOPRO (ABCIXIMAB) INJECTION, SOLUTION [E...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Template:Abciximab Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2], Pratik Bahekar, MBBS [3]


[1]

References

  1. ↑ "REOPRO (ABCIXIMAB) INJECTION, SOLUTION [ELI LILLY AND COMPANY]".

Adapted from the FDA Package Insert.

Retrieved from "https://www.wikidoc.org/index.php?title=Abciximab_nonclinical_toxicology&oldid=935423"